Auvi-q Injection, Solution
Product Images NDC 60842-023

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Auvi-q (NDC 60842-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kaleo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Auvi Q 01)

Chemical structure of epinephrine, the active ingredient in Auvi-Q injection solution. The diagram shows the molecular arrangement, including hydroxyl groups on the aromatic ring and the side chain with an amine group.*

FDA Label Image

Figure A (Auvi Q 02)

An instructional diagram showing the Auvi-Q injection device and its outer case. The device is labeled with components including the speaker, LED lights, viewing window, red safety guard at the needle end, and black base. The outer case is illustrated with a green arrow pointing upward, indicating how to open or access the device.*

FDA Label Image

Figure B (Auvi Q 03)

Instructional illustration showing how to hold and operate the Auvi-Q epinephrine injection device, with arrows indicating directions to remove or activate the device components by pushing up and down.*

FDA Label Image

Figure C (Auvi Q 04)

An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device. The image depicts the device being positioned with arrows pointing downward toward the thigh, indicating the intramuscular injection site.*

FDA Label Image

Figure D (Auvi Q 05)

An instructional diagram showing a person holding an Auvi-Q epinephrine injection device in one hand with the other hand pointing to a timer. The timer indicates 2 seconds, demonstrating the recommended time to hold or activate the device during intramuscular injection.*

FDA Label Image

Figure E (Auvi Q 06)

An instructional illustration showing a person holding an Auvi-Q epinephrine injection device against the thigh, highlighting the injection process. Next to it is a stopwatch indicating 2 seconds, emphasizing the recommended injection time.*

FDA Label Image

Figure A1 (Auvi Q 07)

Illustration of the Auvi-Q Trainer device by kaleo, Inc. It shows the outer case with labeling instructions and the trainer device, highlighting parts such as the speaker, LEDs, housing, base, and safety guard. The image provides guidance for practicing using the device without medication.*

FDA Label Image

Figure A2 (Auvi Q 08)

Auvi-Q Trainer device packaging shows a rectangular black and white box labeled "TRAINER." This product is a non-medicated training aid resembling the Auvi-Q epinephrine injection autoinjector, intended for practice use only by kaleo, Inc.*

FDA Label Image

Figure A3 (Auvi Q 09)

Auvi-Q epinephrine injection, solution in intramuscular dosage forms, shown in packaging with dose strength .3 mg/.3 mL. The label prominently displays the product name Auvi-Q with epinephrine as the active ingredient, highlighting the 30-day expiration and includes step-by-step administration instructions. The labeler is kaleo, Inc.*

FDA Label Image

Figure A4 (Auvi Q 10)

Auvi-Q 0.3 mg epinephrine injection, solution in an intramuscular injector package. The front label features the brand and generic name, strength, and manufacturer kaleo, Inc. The back label provides step-by-step visual instructions for intramuscular administration, including removing the device from the case, placing on the outer thigh, and holding for 5 seconds.*

FDA Label Image

Figure A5 (Auvi Q 11)

Auvi-Q epinephrine injection, USP autoinjector label showing two versions: the front label with dosage strengths .1 mg/.1mL, .15 mg/.15mL, and .3 mg/.3mL, and the back label featuring step-by-step instructions for use including pulling the device from the case and pressing the black end against the thigh. The product is labeled by kaleo, Inc.*

FDA Label Image

Figure B (Auvi Q 12)

An instructional diagram showing hands holding an Auvi-Q epinephrine injection device. The image illustrates steps for using the device, with arrows indicating to slide the top part up and down and a black arrow pointing forward on the middle section, likely to demonstrate activation or preparation movements.*

FDA Label Image

Figure C (Auvi Q 13)

An instructional illustration showing a hand holding an Auvi-Q epinephrine auto-injector device held upright above a thumb positioned on the injection site. Red arrows indicate the positioning and direction for administering the intramuscular injection using the device.*

FDA Label Image

Figure D (Auvi Q 14)

An instructional illustration showing the proper use of Auvi-Q epinephrine injection. It depicts a person holding the injector device against their outer thigh with an arrow indicating motion to press or hold. Adjacent is a stopwatch showing a 2-second interval, indicating how long to hold the device in place during administration.*

FDA Label Image

Figure E (Auvi Q 15)

Illustration showing a person administering an injection from an Auvi-Q epinephrine device into their thigh, accompanied by a stopwatch indicating to hold the device for 2 seconds during administration.*

FDA Label Image

Figure F (Auvi Q 16)

An instructional illustration showing a hand holding an Auvi-Q epinephrine injection device. The image focuses on not holding the black base while inserting the red safety guard, with directional arrows indicating the movement of the guard into place.*

FDA Label Image

Figure G (Auvi Q 17)

An instructional illustration showing hands holding an Auvi-Q epinephrine injection device, demonstrating how to press firmly in opposite directions on the upper and lower parts of the device. The image uses arrows pointing both up and down to indicate the pressing motion required for activation.*

FDA Label Image

0.3 mg 2-plus-1 Carton Label (Auvi Q 18)

Packaging label for Auvi-Q 0.3 mg epinephrine injection, USP auto-injector by kaleo, Inc. The label indicates it contains 2 prefilled auto-injectors and 1 trainer. It is intended for intramuscular injection for allergic emergencies in patients over 66 lb. The label includes storage instructions, ingredients, and a space for pharmacy patient label.*

FDA Label Image

0.3 mg Outer Case Label (Auvi Q 19)

The image shows the packaging label for Auvi-Q epinephrine injection, USP 0.3 mg auto-injector. It includes instructions to pull the device up from the case, storage guidelines, and usage notes, specifying it is for allergic emergencies in patients over 66 lb. The label indicates the product is manufactured for kaleo, Inc. and includes the web address www.auvi-q.com.*

FDA Label Image

0.3 mg Device Label (Auvi Q 20)

Auvi-Q epinephrine injection, USP 0.3 mg auto-injector packaging label by kaleo, Inc. The label provides step-by-step instructions to pull the red safety guard and press the black end against the outer thigh for 2 seconds for allergic emergencies. Additional warnings and manufacturer information are included on the label.*

FDA Label Image

0.15 mg 2-plus-1 Carton Label (Auvi Q 21)

Packaging label for Auvi-Q epinephrine injection, USP 0.15 mg auto-injector by kaleo, Inc. The label indicates 2 prefilled auto-injectors plus 1 trainer included. It is intended for allergic emergencies in patients weighing 33 to 66 lb. The label features usage instructions, storage conditions, and pharmacist dispensing guidance. Manufactured in Richmond, VA.*

FDA Label Image

0.15 mg Outer Case Label (Auvi Q 22)

Auvi-Q 0.15 mg epinephrine injection USP auto-injector label in blue. Instructions on the front include pulling the device from its case and single-use injection directions for allergic emergencies in patients weighing 33 to 66 pounds. The back panel advises storage at room temperature, avoiding refrigeration or freezing, and replacing if the solution is discolored. Manufactured for kaleo, Inc.*

FDA Label Image

0.15 mg Device Label (Auvi Q 23)

Instructional diagram for Auvi-Q epinephrine injection USP 0.15 mg auto-injector showing how to use the device for allergic emergencies. It instructs to pull the red safety guard off, place the black end against the outer thigh, and push firmly for 2 seconds, with a note to seek medical attention. Additional labeling includes manufacturer kaleo, Inc and storage/disposal guidance.*

FDA Label Image

Trainer Carton Label (supplied With 0.3 mg And 0.15 mg Auto-injectors) (Auvi Q 24)

Packaging label for Auvi-Q Trainer by kaleo, Inc. The box is primarily gray and white with red and black text and indicates it is a reusable trainer containing no active drug or needle. The label instructs users to practice often and register for refill reminders. It includes the kaleo logo, barcode, manufacturing details, and emphasizes the absence of active drug or needle.*

FDA Label Image

Trainer Outer Case Label (supplied With 0.3 mg And 0.15 mg Auto-injectors) (Auvi Q 25)

Packaging label for the Auvi-Q Trainer device by kaleo, Inc. The label indicates this is a reusable trainer for Auvi-Q epinephrine injection devices, containing no active drug or needle. It instructs users to pull the device up from the case and notes the trainer is for practice use only, with instructions found inside. The product is manufactured for kaleo, with origin Thailand marked.*

FDA Label Image

Trainer Device Label (supplied With 0.3 mg And 0.15 mg Auto-injectors) (Auvi Q 26)

Packaging label for Auvi-Q Trainer, a reusable practice device for the Auvi-Q epinephrine injection. The label includes instructions to pull the red safety guard, place the black end against the outer thigh, and push firmly for 2 seconds. It states that the trainer contains no active drug or needle. Labeler kaleo, Inc is noted along with reset instructions for replacing the red safety guard and gray outer case.*

FDA Label Image

0.1 mg 2-plus-1 Carton Label (Auvi Q 27)

Packaging label for Auvi-q 0.1 mg epinephrine injection, USP auto-injector. The carton includes two prefilled auto-injectors and one trainer for allergic emergencies in patients weighing 16.5 to 33 lb. The labeler is kaleo, Inc. Instructions on storage and handling are included, with notes on contents of each 0.1 mL dose.*

FDA Label Image

0.1 mg Outer Case Label (Auvi Q 28)

Label for Auvi-q epinephrine injection, USP 0.1 mg auto-injector by kaleo, Inc. The label includes instructions to pull the device up from its case and storage conditions advising against refrigeration or freezing, protection from heat and light, and room temperature storage. It is indicated for single-use injection in allergic emergencies, specifying patient weight 16.5 to 33 lb, with a note to refill the prescription after use.*

FDA Label Image

0.1 mg Device Label (Auvi Q 29)

Auvi-Q 0.1 mg epinephrine injection auto-injector packaging label, a single-use intramuscular injection for allergic emergencies. The front label features instructions to pull the red safety guard and press the black end against the outer thigh, with illustrations. Labeler is kaleo, Inc. Contains 0.1 mg epinephrine with sodium chloride, sodium bisulfite, and water for injection.*

FDA Label Image

Trainer Carton Label (supplied With 0.1 mg Auto-injectors) (Auvi Q 30)

Packaging label for Auvi-Q Trainer by kaleo, Inc., a reusable practice injection device containing no active drug or needle. The label is predominantly gray and white with clear warnings that it contains no active drug or needle, and includes registration and manufacturer information. It is designed to practice the use of Auvi-Q epinephrine injection.*

FDA Label Image

Trainer Outer Case Label (supplied With 0.1 mg Auto-injectors) (Auvi Q 31)

Packaging label for Auvi-Q trainer device by kaleo, Inc. The label indicates the product is a reusable trainer containing no active drug or needle, used to practice Auvi-Q injection techniques. The label instructs users to pull the trainer from the case and notes that instructions for use are found inside the trainer. It also includes a manufacturer reference and states the trainer is made in Thailand.*

FDA Label Image

Trainer Device Label (supplied With 0.1 mg Auto-injectors) (Auvi Q 32)

Packaging label for Auvi-Q Trainer, a reusable practice device for epinephrine injection. The label includes instructions to pull the red safety guard and place the black end against the outer thigh for use. It states that the trainer contains no active drug or needle and has reset instructions. Manufactured for kaleo, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.